Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibronectin leucine-rich transmembrane protein 3 (FLRT3) is a member of the FLRT family involved in cell adhesion and receptor signaling, with structural similarity to small leucine-rich proteoglycans found in the extracellular matrix[1][2][3][5]. FLRT3 plays key roles during embryonic development and in the adult, notably in the nervous system as a postsynaptic ligand for latrophilin receptors, where it is important for excitatory synapse formation[1][3]. It also modulates intercellular adhesion, neuronal migration, axon guidance (acting as a co-receptor with Robo1 for Netrin-1), and participates in FGF signaling by interacting with FGFR1, regulating tissue morphogenesis such as heart and craniofacial development[1][3]. FLRT3 is expressed in numerous tissues and has been implicated in pathologies including cancer—where it may help tumor cells evade immune detection—and genetic disorders such as high myopia and hypogonadotropic hypogonadism[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibronectin leucine-rich transmembrane protein 3 (FLRT3).